130 likes | 186 Views
Learn about SAMHSA's Opioid Response Network, medical marijuana treatment, patient requirements, barriers to treatment, and available resources. Obtain training, technical assistance, and access to medication. Explore eligibility, registration, and insurance coverage information.
E N D
Brief Overview of Substance Use Disorder Joan Salmon, LCSW-R 05/22/2019
Working with communities to address the opioid crisis. • SAMHSA’s State Targeted Response Technical Assistance (STR-TA) grant created the Opioid Response Network to assist STR grantees, individuals and other organizations by providing the resources and technical assistance they need locally to address the opioid crisis . • Technical assistance is available to support the evidence-based prevention, treatment, and recovery of opioid use disorders.
Working with communities to address the opioid crisis. • The Opioid Response Network (ORN) provides local, experienced consultants in prevention, treatment and recovery to communities and organizations to help address this opioid crisis. • The ORN accepts requests for education and training. • Each state/territory has a designated team, led by a regional Technology Transfer Specialist (TTS), who is an expert in implementing evidence-based practices.
Contact the Opioid Response Network • To ask questions or submit a technical assistance request: • Visit www.OpioidResponseNetwork.org • Email orn@aaap.org • Call 401-270-5900
Overall Mission To provide training and technical assistance via local experts to enhance prevention, treatment (especially medication-assisted treatment like buprenorphine, naltrexone, and methadone), and recoveryefforts across the country addressing state and local - specific needs.
Definition • The term medical marijuana refers to using the whole, unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions. The U.S. Food and Drug Administration (FDA) has not recognized or approved the marijuana plant as medicine. • Cannabinoids are chemicals related to delta-9-tetrahydrocannabinol (THC), marijuana’s main mind-altering ingredient that makes people "high." The marijuana plant contains more than 100 cannabinoids.
Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. • THC can increase appetite and reduce nausea. THC may also decrease pain, inflammation (swelling and redness), and muscle control problems. Unlike THC, CBD is a cannabinoid that doesn't make people "high." These drugs aren't popular for recreational use because they aren't intoxicating.
Individuals may be eligible for medical marijuana if they have been diagnosed with one or more of the following severe debilitating or life threatening conditions: HIV; AIDS, Cancer, ALS, MS and PTSD • Patient’s must register with NYS DOH in order to obtain medical marijuana. They must be certified by a registered practitioner before they can apply. A $50 application fee is currently being waived. The patient will obtain a registration card once their application is approved
A caregiver for a patient who is unable to obtain the medication can also be registered as an authorized person to assist with medication distribution. • Once patients are registered they can obtain the medication from one of the approved dispensing facilities. https://www.health.ny.gov/regulations/medical_marijuana/application/selected_applicants.htm • Medical marijuana is not covered by insurance due to the illegal classification of the drug.
There are resources in place to provide the patient with discounts to purchase the medication. https://www.firstquotehealth.com/health-insurance-news/health-insurance-medical-marijuana-cbd-oil
Barriers To Treatment • Stigma associated with SUD • Patient motivation and commitment to the treatment process. • Insurance • Patient’s misuse